Suppr超能文献

慢性L-精氨酸甲酯治疗通过外周组织和大脑中的不同机制导致高血压:中枢内皮型一氧化氮合酶的作用。

Chronic L-Name-Treatment Produces Hypertension by Different Mechanisms in Peripheral Tissues and Brain: Role of Central eNOS.

作者信息

Pechanova Olga, Vrankova Stanislava, Cebova Martina

机构信息

Centre of Experimental Medicine, Slovak Academy of Sciences, Institute of Normal and Pathological Physiology, 813 71 Bratislava, Slovakia.

出版信息

Pathophysiology. 2020 Dec 15;27(1):46-54. doi: 10.3390/pathophysiology27010007.

Abstract

The goal of our study was to analyze the time course of the effect of N-nitro-L-arginine methyl ester (L-NAME) on nitric oxide synthase (NOS) isoforms and nuclear factor-κB (NF-κB) protein expression, total NOS activity, and blood pressure (BP) in rats. Adult 12-week-old male Wistar rats were subjected to treatment with L-NAME (40 mg/kg/day) for four and seven weeks. BP was increased after 4- and 7-week L-NAME treatments. NOS activity decreased after 4-week-L-NAME treatment; however, the 7-week treatment increased NOS activity in the aorta, heart, and kidney, while it markedly decreased NOS activity in the brainstem, cerebellum, and brain cortex. The 4-week-L-NAME treatment increased eNOS expression in the aorta, heart, and kidney and this increase was amplified after 7 weeks of treatment. In the brain regions, eNOS expression remained unchanged after 4-week L-NAME treatment and prolonged treatment led to a significant decrease of eNOS expression in these tissues. NF-κB expression increased in both peripheral and brain tissues after 4 weeks of treatment and prolongation of treatment decreased the expression in the aorta, heart, and kidney. In conclusion, decreased expression of eNOS in the brain regions after 7-week L-NAME treatment may be responsible for a remarkable decrease of NOS activity in these regions. Since the BP increase persisted after 7 weeks of L-NAME treatment, we hypothesize that central regulation of BP may contribute significantly to L-NAME-induced hypertension.

摘要

我们研究的目的是分析N-硝基-L-精氨酸甲酯(L-NAME)对大鼠一氧化氮合酶(NOS)亚型、核因子-κB(NF-κB)蛋白表达、总NOS活性及血压(BP)影响的时间进程。12周龄成年雄性Wistar大鼠接受L-NAME(40mg/kg/天)治疗4周和7周。L-NAME治疗4周和7周后血压升高。L-NAME治疗4周后NOS活性降低;然而,7周治疗使主动脉、心脏和肾脏中的NOS活性增加,而使脑干、小脑和大脑皮层中的NOS活性显著降低。L-NAME治疗4周后主动脉、心脏和肾脏中内皮型一氧化氮合酶(eNOS)表达增加,且这种增加在治疗7周后进一步放大。在脑区,L-NAME治疗4周后eNOS表达未改变,长期治疗导致这些组织中eNOS表达显著降低。治疗4周后外周和脑组织中NF-κB表达均增加,延长治疗则使主动脉、心脏和肾脏中的表达降低。总之,L-NAME治疗7周后脑区eNOS表达降低可能是这些区域NOS活性显著降低的原因。由于L-NAME治疗7周后血压升高持续存在,我们推测血压的中枢调节可能对L-NAME诱导的高血压有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c3/8830472/710d0cec4ca3/pathophysiology-27-00007-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验